Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.096 | 0.09 |